Developer docs
API playgroundTry for free, no card

Search company profiles

Haukeland University Hospital

Full company profile

uuid003cmnf

Namestring
Haukeland University Hospital
Legal namestring
Helse Bergen HF, Haukeland universitetssjukehus
Websiteurl
helse-bergen.no
Company typeenum
Private
Founded yearint
1912
Descriptiontext

Haukeland University Hospital (legally Helse Bergen HF) is a public university hospital in Bergen, Norway, providing specialist healthcare to residents of Western Norway as part of the national specialist healthcare system (spesialisthelsetenesta). It operates under Helse Vest Regional Health Authority (Helse Vest RHF) and serves as the primary teaching hospital for the University of Bergen (UiB). The hospital delivers the full spectrum of secondary and tertiary care — inpatient, outpatient, emergency, surgical, maternity, pediatric, psychiatric, and rehabilitation services — distributed across its main Bergen campus plus units in Sandviken (psychiatric division), Nordås (physical medicine and rehabilitation), Hagevik (Kysthospitalet), and Voss (Voss sjukehus). It also supports clinical research and medical education through its UiB affiliation.

The hospital's clinical technology stack is anchored by DIPS Arena as the main electronic patient journal, supplemented by MEONA for medication charts, Sectra for radiology imaging, and Unilab for laboratory systems. Patient records are shared across 11+ Helse Vest institutions, and patients over 16 access their journal digitally through the national Helsenorge.no portal. Secure clinician-patient communication is handled through VestDialog. IT operations and most information systems are managed by Helse Vest IKT AS, the regional IT services entity owned by the parent authority.

The hospital is funded primarily through annual government allocations from Helse Vest RHF, supplemented by standardized patient copayments (egenandel) — which carry frikort exemption thresholds — and ancillary fee streams such as parking. It maintains a flat leadership structure with 28 directors at division, clinic, and department level reporting directly to the managing director. The 2023 opening of Glasblokkene 5-8 centralized all child and youth somatic and psychiatric care in one facility, including the uniquely Norwegian Energisenteret for barn og unge.

Short descriptiontext

Haukeland University Hospital (Helse Bergen HF) is a Norwegian public university hospital in Bergen that delivers specialist healthcare to Western Norway under Helse Vest RHF, operating multi-site clinical services with shared regional patient records and a UiB teaching affiliation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersBergen, Norway
HQ citystring
Bergen
HQ countrystring
Norway
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialized hospital care, university hospital services, emergency medical services, pediatric hospital care, psychiatric healthcare
Industry1 code
1Children’s Hospitals (Acute Care)
CodeHLAFAAAIPrimaryNo
NAICS code3 codes
  • General Medical and Surgical Hospitals6221
  • General Medical and Surgical Hospitals62211
  • General Medical and Surgical Hospitals622110
SIC code2 codes
  • Services-Hospitals8060
  • Services-General Medical & Surgical Hospitals, Nec8062
Product category
Hospital Healthcare Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Government Healthcare Funding
TypeSubscription Recurring
Description

As a public university hospital within the Norwegian specialist healthcare system (spesialisthelsetenesta), Haukeland University Hospital is primarily funded through government allocations from Helse Vest RHF and national health authorities. Patients pay standardized copayments (egenandel) for services with exemptions through frikort (exemption cards) once spending thresholds are reached.

helse-bergen.no
2Patient Copayments and Fees
TypeUsage Based
Description

Patients pay standardized fees for treatments, examinations, and parking. Fee exemptions exist for specific groups including blood donors, dialysis patients, those with mobility impairments, and long-term patients.

helse-bergen.no
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
Pricing details2 tiers
1Standard healthcare services with government-subsidized copayments
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Patients pay standardized copayments (egenandel) for treatments. Frikort (exemption card) issued when annual spending exceeds threshold.

helse-bergen.no
2Parking fees at Haukeland University Hospital
ModelUsage-basedBilling cadencePay-as-you-go
Notes

Weekdays 08-17: 16 kr per 20 min, max 265 kr/day. Evening (17-21): 11 kr per 30 min. Night (21-08): 6 kr/hour, max 42 kr. Saturday-Sunday: 16 kr/hour, max 111 kr/day. Caregiver parking card: 400 kr/week or for 7 entries/exits.

helse-bergen.no
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Haukeland University Hospital is a public university hospital providing specialized healthcare services across Western Norway, including inpatient treatment, outpatient clinics, emergency care, surgical services, maternity care, pediatric services, psychiatric care, rehabilitation, and diagnostic imaging. The hospital also operates the unique Energisenteret for barn og unge (Energy Center for Children and Youth), conducts clinical research in collaboration with the University of Bergen, and maintains a shared electronic patient journal system across 11+ institutions in the Helse Vest region.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Electronic access to patient journal for patients over 16 years
+1 more record
Product and service10 records
1Specialized Hospital Care
CategoryInpatient and outpatient healthcare
2Emergency Care Services
CategoryEmergency medical services
3Maternity and Pediatric Care
CategoryMaternity and pediatric healthcare
4Psychiatric Care
CategoryMental health services
5Rehabilitation Services
CategoryRehabilitation services
6Diagnostic Imaging and Laboratory Services
CategoryDiagnostic services
7Energisenteret for barn og unge
CategorySpecialized youth healthcare facility
8Clinical Research Studies
CategoryClinical research
9VestDialog Secure Messaging
CategoryPatient communication services
10Chaplaincy and Pastoral Care Services (Preste- og samtaletenesta)
CategoryPastoral care services
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Haukeland University Hospital operates in collaboration with the University of Bergen (UiB) as a university hospital. This partnership supports medical research, education, and clinical training. Medical students are involved in hospital operations including initiatives like the Urtehagen (Herb Garden) project led by Klima=Helse.

Strategic tierCoreTypeTechnology or Integration
Description

Hospitals in Helse Vest have established a collaborative patient journal system. Partnering institutions include: Betanien sykehus, Haraldsplass diakonale sykehus, Haugesund Sanitetsforenings revmatismesjukehus, Helse Bergen HF, Helse Fonna HF, Helse Førde HF, Helse Stavanger HF, NKS Jæren distriktspsykiatriske senter, NKS Olaviken alderspsykiatriske sjukehus, Solli DPS, and Voss DPS NKS Bjørkeli.

Strategic tierCoreTypeTechnology or Integration
Description

Helse Vest IKT AS is a data processor for the hospital, managing and maintaining most information systems. The company is owned by Helse Vest RHF and operates under contract with the hospital.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner organization using Energisenteret facilities for activities for children and youth with autism spectrum conditions.

5Touretteforeningen
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner organization using Energisenteret facilities for activities for children and youth with Tourette syndrome.

helse-bergen.no
6CP-Foreningen
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner organization for cerebral palsy using Energisenteret facilities.

helse-bergen.no
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sports cluster consisting of Helse Bergen, Vestland Idrettskrets, Bergen kommune, Vestland Fylkeskommune, Høgskulen på Vestlandet, Universitetet i Bergen, Olympiatoppen Vest, and Sportsklubben Brann. Aims to strengthen public health, sports, and physical activity in the Vestland region.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Healthcare cluster with a dedicated professional group for children and youth closely connected to Energisenteret. Focuses on development and collaboration in quality of life, prevention, coping, and seamless services.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Municipality partner in Idrettsklynge Vest and user of Energisenteret facilities.

10Høgskulen på Vestlandet (Western Norway University of Applied Sciences)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Educational partner in Idrettsklynge Vest and provides students for practice at Energisenteret. Collaborates on research and development.

helse-bergen.no
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Norway's largest university hospital and the most direct peer: provides comprehensive specialist and academic medical services, partners with University of Oslo, and operates under a similar public regional health authority structure as Haukeland/Helse Vest.

TypeDirect peer
Description

Trondheim-based university hospital affiliated with NTNU; comparable academic medical center offering the same breadth of specialist services and integrated research/teaching mission in Central Norway.

TypeRegional player
Description

Sister health trust in Helse Vest providing hospital and psychiatric services in Haugesund/Sunnhordland; comparable operating model and shared regional IT/EPR infrastructure, though smaller and less specialty-intensive.

4University Hospital of North Norway
TypeDirect peer
Description

Tromsø-based university hospital affiliated with UiT; equivalent northern Norway academic medical center with comparable breadth of specialties, research activity, and public-health-trust governance.

TypeDirect peer
Description

Large university hospital serving the Oslo region with University of Oslo affiliation; directly comparable in scale, service mix, and publicly-funded operating model.

TypeRegional player
Description

Helse Vest health trust serving Sogn og Fjordane; operates on the same shared DIPS Arena EPR and public-trust governance as Haukeland, providing a comparable but smaller regional hospital footprint.

TypeDirect peer
Description

Denmark's largest university hospital affiliated with Aarhus University; comparable Nordic academic medical center with comprehensive specialist services, research integration, and public funding model.

TypeBroad incumbent
Description

Stockholm's academic medical center tied to Karolinska Institutet; comparable Nordic university hospital with broader research scale and a similar publicly-funded specialist delivery mandate.

TypeDirect peer
Description

Gothenburg-based Nordic university hospital affiliated with University of Gothenburg; operates the same academic medical center model with comprehensive specialist services and integrated research/teaching.

10Stavanger University Hospital
TypeDirect peer
Description

Largest university hospital in the Stavanger region and Helse Vest peer institution; shares the regional EPR platform and offers comparable multi-specialty clinical, research, and teaching services.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration10 records

Each record includes

Title, Type, Description, Source

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Haukeland University Hospital

Hospital Healthcare Serviceshelse-bergen.no

Haukeland University Hospital (Helse Bergen HF) is a Norwegian public university hospital in Bergen that delivers specialist healthcare to Western Norway under Helse Vest RHF, operating multi-site clinical services with shared regional patient records and a UiB teaching affiliation.

What Haukeland University Hospital does

Haukeland University Hospital (legally Helse Bergen HF) is a public university hospital in Bergen, Norway, providing specialist healthcare to residents of Western Norway as part of the national specialist healthcare system (spesialisthelsetenesta). It operates under Helse Vest Regional Health Authority (Helse Vest RHF) and serves as the primary teaching hospital for the University of Bergen (UiB). The hospital delivers the full spectrum of secondary and tertiary care — inpatient, outpatient, emergency, surgical, maternity, pediatric, psychiatric, and rehabilitation services — distributed across its main Bergen campus plus units in Sandviken (psychiatric division), Nordås (physical medicine and rehabilitation), Hagevik (Kysthospitalet), and Voss (Voss sjukehus). It also supports clinical research and medical education through its UiB affiliation.

The hospital's clinical technology stack is anchored by DIPS Arena as the main electronic patient journal, supplemented by MEONA for medication charts, Sectra for radiology imaging, and Unilab for laboratory systems. Patient records are shared across 11+ Helse Vest institutions, and patients over 16 access their journal digitally through the national Helsenorge.no portal. Secure clinician-patient communication is handled through VestDialog. IT operations and most information systems are managed by Helse Vest IKT AS, the regional IT services entity owned by the parent authority.

The hospital is funded primarily through annual government allocations from Helse Vest RHF, supplemented by standardized patient copayments (egenandel) — which carry frikort exemption thresholds — and ancillary fee streams such as parking. It maintains a flat leadership structure with 28 directors at division, clinic, and department level reporting directly to the managing director. The 2023 opening of Glasblokkene 5-8 centralized all child and youth somatic and psychiatric care in one facility, including the uniquely Norwegian Energisenteret for barn og unge.

Haukeland University Hospital firmographics

Firmographics
Name
Haukeland University Hospital
Legal name
Helse Bergen HF, Haukeland universitetssjukehus
Website
https://helse-bergen.no
Company type
Private
Founded year
1912
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Haukeland University Hospital (Helse Bergen HF) is a Norwegian public university hospital in Bergen that delivers specialist healthcare to Western Norway under Helse Vest RHF, operating multi-site clinical services with shared regional patient records and a UiB teaching affiliation.
Ownership category
akta.pro rank

Where Haukeland University Hospital is headquartered

Location

Headquarters

HQ city
Bergen
HQ country
Norway
HQ region
Europe

Offices5 records

Markets served

Haukeland University Hospital business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. Government Healthcare Funding: As a public university hospital within the Norwegian specialist healthcare system (spesialisthelsetenesta), Haukeland University Hospital is primarily funded through government allocations from Helse Vest RHF and national health authorities. Patients pay standardized copayments (egenandel) for services with exemptions through frikort (exemption cards) once spending thresholds are reached.
  2. Patient Copayments and Fees: Patients pay standardized fees for treatments, examinations, and parking. Fee exemptions exist for specific groups including blood donors, dialysis patients, those with mobility impairments, and long-term patients.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goStandard healthcare services with government-subsidized copayments
Usage-basedPay-as-you-goParking fees at Haukeland University Hospital

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Haukeland University Hospital product offering

Product offering

Core offering

Haukeland University Hospital is a public university hospital providing specialized healthcare services across Western Norway, including inpatient treatment, outpatient clinics, emergency care, surgical services, maternity care, pediatric services, psychiatric care, rehabilitation, and diagnostic imaging. The hospital also operates the unique Energisenteret for barn og unge (Energy Center for Children and Youth), conducts clinical research in collaboration with the University of Bergen, and maintains a shared electronic patient journal system across 11+ institutions in the Helse Vest region.

Differentiator

Problem solved

Functional benefit

Products and services

  • Specialized Hospital Care
  • Emergency Care Services
  • Maternity and Pediatric Care
  • Psychiatric Care
  • Rehabilitation Services
  • Diagnostic Imaging and Laboratory Services
  • Energisenteret for barn og unge
  • Clinical Research Studies
  • VestDialog Secure Messaging
  • Chaplaincy and Pastoral Care Services (Preste- og samtaletenesta)

Quantifiable outcome

  • Electronic access to patient journal for patients over 16 years
  • +1 more outcomes

Companies that use Haukeland University Hospital

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Haukeland University Hospital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability1 record

Feature3 records

Haukeland University Hospital partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • University of Bergen (UiB)coreStrategic or Co-development PartnerHaukeland University Hospital operates in collaboration with the University of Bergen (UiB) as a university hospital. This partnership supports medical research, education, and clinical training. Medical students are involved in hospital operations including initiatives like the Urtehagen (Herb Garden) project led by Klima=Helse.
  • Helse Vest Patient Journal Collaboration (11+ institutions)coreTechnology or IntegrationHospitals in Helse Vest have established a collaborative patient journal system. Partnering institutions include: Betanien sykehus, Haraldsplass diakonale sykehus, Haugesund Sanitetsforenings revmatismesjukehus, Helse Bergen HF, Helse Fonna HF, Helse Førde HF, Helse Stavanger HF, NKS Jæren distriktspsykiatriske senter, NKS Olaviken alderspsykiatriske sjukehus, Solli DPS, and Voss DPS NKS Bjørkeli.
  • Helse Vest IKT AScoreTechnology or IntegrationHelse Vest IKT AS is a data processor for the hospital, managing and maintaining most information systems. The company is owned by Helse Vest RHF and operates under contract with the hospital.
  • AutismeforeningenminorStrategic or Co-development PartnerPartner organization using Energisenteret facilities for activities for children and youth with autism spectrum conditions.
  • TouretteforeningenminorStrategic or Co-development PartnerPartner organization using Energisenteret facilities for activities for children and youth with Tourette syndrome.
  • CP-ForeningenminorStrategic or Co-development PartnerPartner organization for cerebral palsy using Energisenteret facilities.
  • Idrettsklynge VestminorStrategic or Co-development PartnerSports cluster consisting of Helse Bergen, Vestland Idrettskrets, Bergen kommune, Vestland Fylkeskommune, Høgskulen på Vestlandet, Universitetet i Bergen, Olympiatoppen Vest, and Sportsklubben Brann. Aims to strengthen public health, sports, and physical activity in the Vestland region.
  • Alrek helseklyngeminorStrategic or Co-development PartnerHealthcare cluster with a dedicated professional group for children and youth closely connected to Energisenteret. Focuses on development and collaboration in quality of life, prevention, coping, and seamless services.
  • Bergen kommuneminorStrategic or Co-development PartnerMunicipality partner in Idrettsklynge Vest and user of Energisenteret facilities.
  • Høgskulen på Vestlandet (Western Norway University of Applied Sciences)minorStrategic or Co-development PartnerEducational partner in Idrettsklynge Vest and provides students for practice at Energisenteret. Collaborates on research and development.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Haukeland University Hospital competitors and assessment

Company assessment

Direct peers

  • Oslo University Hospital: Norway's largest university hospital and the most direct peer: provides comprehensive specialist and academic medical services, partners with University of Oslo, and operates under a similar public regional health authority structure as Haukeland/Helse Vest.
  • St. Olavs Hospital: Trondheim-based university hospital affiliated with NTNU; comparable academic medical center offering the same breadth of specialist services and integrated research/teaching mission in Central Norway.
  • University Hospital of North Norway: Tromsø-based university hospital affiliated with UiT; equivalent northern Norway academic medical center with comparable breadth of specialties, research activity, and public-health-trust governance.
  • Akershus University Hospital: Large university hospital serving the Oslo region with University of Oslo affiliation; directly comparable in scale, service mix, and publicly-funded operating model.
  • Aarhus University Hospital: Denmark's largest university hospital affiliated with Aarhus University; comparable Nordic academic medical center with comprehensive specialist services, research integration, and public funding model.
  • Sahlgrenska University Hospital: Gothenburg-based Nordic university hospital affiliated with University of Gothenburg; operates the same academic medical center model with comprehensive specialist services and integrated research/teaching.
  • Stavanger University Hospital: Largest university hospital in the Stavanger region and Helse Vest peer institution; shares the regional EPR platform and offers comparable multi-specialty clinical, research, and teaching services.

Regional players

  • Helse Fonna HF: Sister health trust in Helse Vest providing hospital and psychiatric services in Haugesund/Sunnhordland; comparable operating model and shared regional IT/EPR infrastructure, though smaller and less specialty-intensive.
  • Helse Førde HF: Helse Vest health trust serving Sogn og Fjordane; operates on the same shared DIPS Arena EPR and public-trust governance as Haukeland, providing a comparable but smaller regional hospital footprint.

Broad incumbents

  • Karolinska University Hospital: Stockholm's academic medical center tied to Karolinska Institutet; comparable Nordic university hospital with broader research scale and a similar publicly-funded specialist delivery mandate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Haukeland University Hospital social profiles

Digital presence

Haukeland University Hospital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Haukeland University Hospital leadership team

Management profile

Number of profiles

Profiles9 records

Haukeland University Hospital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Haukeland University Hospital M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Haukeland University Hospital

What does Haukeland University Hospital do?

Haukeland University Hospital is a public university hospital providing specialized healthcare services across Western Norway, including inpatient treatment, outpatient clinics, emergency care, surgical services, maternity care, pediatric services, psychiatric care, rehabilitation, and diagnostic imaging. The hospital also operates the unique Energisenteret for barn og unge (Energy Center for Children and Youth), conducts clinical research in collaboration with the University of Bergen, and maintains a shared electronic patient journal system across 11+ institutions in the Helse Vest region.

Is Haukeland University Hospital a public or private company?

Haukeland University Hospital is a private company. It is classified as state government owned and is currently operating.

When was Haukeland University Hospital founded?

Haukeland University Hospital was founded in 1912. It employs 5,001 to 10,000 people.

Where is Haukeland University Hospital based?

Haukeland University Hospital is headquartered in Bergen, Norway, in the Europe region.

How does Haukeland University Hospital make money?

Two revenue lines are on record. Government Healthcare Funding is the primary driver. The others are patient Copayments and Fees.

Who are Haukeland University Hospital's main competitors?

Direct peers on record are Oslo University Hospital, St. Olavs Hospital, University Hospital of North Norway, Akershus University Hospital, Aarhus University Hospital, Sahlgrenska University Hospital and Stavanger University Hospital. Regional players are Helse Fonna HF and Helse Førde HF. Karolinska University Hospital is listed as a broad incumbent.

Does Haukeland University Hospital have an API?

No public API is recorded for Haukeland University Hospital.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
DevdiscourseAI in Healthcare Delivers Real Results, but WHO Says Better Policies Will Decide Its Global SuccessThe World Health Organization Regional Office for Europe released a report presenting evidence from 11 real-world AI implementations across Finland, Israel, Latvia, Norway, Portugal, Spain and the United Kingdom, demonstrating measurable improvements in clinical care and hospital operations including a 25% increase in pulmonary embolism detection at Helsinki University Hospital and up to 80% reductions in organ-contouring time at Norway's Haukeland University Hospital. The report argues that successful AI adoption depends on strong governance, reliable health data, skilled professionals and continuous monitoring rather than sophisticated algorithms alone, and calls for investment in digital infrastructure, workforce training and national governance systems. With the global health workforce expected to face an 11 million shortage by 2030, WHO recommends that countries adopt AI through a phased approach based on institutional capacity, emphasizing that responsible implementation rather than technology alone will determine whether AI delivers lasting improvements in health outcomes.AijournForesee’s Oral ALDH2 Activator, Mirivadelgat to Enter Clinical Testing in Parkinson’s Disease in the SLEIPNIR Phase 2a Platform TrialForesee Pharmaceuticals announced that its oral ALDH2 activator mirivadelgat has been selected to enter clinical testing in Parkinson's disease as part of the SLEIPNIR Phase 2a platform trial, in collaboration with Haukeland University Hospital in Bergen, Norway. The biomarker-driven trial will enroll 40 participants randomized 3:1 to receive mirivadelgat or placebo over 12 weeks, assessing CNS penetration, target engagement, and safety. The trial is funded by Cure Parkinson's and other Norwegian research bodies, with the goal of generating data to prioritize treatments for larger efficacy trials.Investing.comForesee’s mirivadelgat selected for Parkinson’s trial in Norway By Investing.comForesee Pharmaceuticals announced that its oral ALDH2 activator mirivadelgat has been selected for clinical testing in Parkinson's disease as part of the SLEIPNIR Phase 2a platform trial at Haukeland University Hospital in Bergen, Norway. The randomized study will enroll 40 participants with Parkinson's disease in a 3:1 ratio receiving mirivadelgat or placebo over 12 weeks, funded by the UK-based charity Cure Parkinson's. Foresee is a Taiwan and US-based biopharmaceutical company with a market capitalization of $385 million.Investing.comhttps://in.investing.com/news/stock-market-news/foresees-mirivadelgat-selected-for-parkinsons-trial-in-norway-93CH-5443861Foresee Pharmaceuticals announced that its oral ALDH2 activator mirivadelgat has been selected for clinical testing in Parkinson's disease as part of the SLEIPNIR Phase 2a platform trial in Norway. The trial, conducted in collaboration with Haukeland University Hospital in Bergen, will enroll 40 participants randomized 3:1 to receive mirivadelgat or placebo for 12 weeks. The SLEIPNIR platform is funded by UK-based charity Cure Parkinson's and evaluates disease-modifying therapies focusing on brain penetration and biomarker effects.PR NewswireForesee's Oral ALDH2 Activator, Mirivadelgat to Enter Clinical Testing in Parkinson's Disease in the SLEIPNIR Phase 2a Platform TrialForesee Pharmaceuticals announced that its oral ALDH2 activator mirivadelgat has been selected to enter clinical testing in Parkinson's disease as part of the SLEIPNIR Phase 2a platform trial, conducted in collaboration with Haukeland University Hospital in Bergen, Norway. The trial will randomize 40 eligible Parkinson's disease participants 3:1 to receive mirivadelgat once daily or matching placebo for 12 weeks, assessing CNS penetration, biological target engagement, and safety. Foresee's CEO and CSO expressed confidence that the study will provide foundational data supporting further development of ALDH2 activation as a disease-modifying approach for Parkinson's and potentially other CNS diseases.GlobeNewswireSPARK NS and Haukeland University Hospital Announce Clinical Trial of D-Serine for Modifying Parkinson’s Disease ProgressionSPARK NS and Haukeland University Hospital announced a Phase 2b trial of orally administered D-Serine for Parkinson's disease. The trial will enroll 100 patients in Norway to assess symptom improvement or disease progression delay. It is the first trial from SPARK NS's Translational Research Program.PR NewswireEANM'25: Metabolically active visceral fat linked to aggressive endometrial cancer, new study revealsResearch presented at the 38th Annual Congress of the European Association of Nuclear Medicine found that high metabolic activity of visceral fat, not just fat volume, may be associated with more aggressive endometrial cancer. Researchers from Haukeland University Hospital and the University of Bergen analyzed PET/CT scans of 274 women and found that those with higher visceral fat metabolic activity were significantly more likely to present with advanced stage disease and lymph node metastases. The technique is not yet ready for routine clinical use, but future approaches including standardized imaging analyses and AI may help identify high-risk patients and guide treatment decisions.Stock TitanNiagen Secures Exclusive Rights for Parkinson's Disease Therapy DevelopmentNiagen Bioscience entered a worldwide exclusive commercial license agreement with Haukeland University Hospital in Norway to develop and commercialize its patented nicotinamide riboside (Niagen) as a potential Parkinson's disease therapy. The agreement includes data from the NOPARK phase III trial, which enrolled 400 participants and is expected to be published by end of 2025. Niagen retains the right to commercialize or sublicense the program.Investing.comNiagen Bioscience secures exclusive rights for Parkinson’s treatment By Investing.comNiagen Bioscience secured an exclusive worldwide license with Haukeland University Hospital to develop its nicotinamide riboside molecule for Parkinson's disease. The agreement grants rights to data from the NOPARK phase III trial of 400 patients, with results expected by end of 2025. The company also raised its full-year growth outlook to 20-25%.Investing.comNiagen Bioscience secures exclusive rights for Parkinson’s treatment By Investing.comNiagen Bioscience secured an exclusive worldwide license from Haukeland University Hospital to develop nicotinamide riboside for Parkinson's disease. The agreement grants access to NOPARK trial data from 400 patients, with results expected by end of 2025. The company also raised its full-year growth outlook to 20-25%.